TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Novo Nordisk Pharmatech A/S
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,310,754
|
895,294
|
851,405 |
| Earnings before taxes |
146,933
|
73,709
|
201,763 |
| Total assets |
1,885,678
|
1,446,971
|
880,067 |
| Current assets |
942,297
|
753,803
|
339,723 |
| Current liabilities |
682,543
|
350,523
|
124,515 |
| Equity capital |
1,141,791
|
1,032,003
|
715,479 |
| - share capital |
14,890
|
14,966
|
13,753 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
60.6%
|
71.3%
|
81.3% |
| Turnover per employee |
8,738
|
5,969
|
5,676 |
| Profit as a percentage of turnover |
11.2%
|
8.2%
|
23.7% |
| Return on assets (ROA) | |||
| Current ratio |
138.1%
|
215.1%
|
272.8% |
| Return on equity (ROE) |
12.9%
|
7.1%
|
28.2% |
| Change turnover |
420,047
|
-31,154
|
-66,901 |
| Change turnover % |
47%
|
-3%
|
-7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.